Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions

Nature Medicine

Volumn 1, Issue 12, 1995, Pages 1257-1260

  Weinstat Saslow, Debra ^a   Merino, Maria J ^a   Manrow, Richard E ^a   Lawrence, Julia A ^a   Bluth, Ray F ^b   Wittenbel, Karl D ^b   Simpson, Jean F ^c   Page, David L ^b   Steeg, Patricia S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLINE;

ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; BREAST TUMOR; CANCER INVASION; CARCINOMA IN SITU; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

BREAST NEOPLASMS; CARCINOMA, INFILTRATING DUCT; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COHORT STUDIES; CYCLIN D1; CYCLINS; FEMALE; FIBROCYSTIC DISEASE OF BREAST; GENE EXPRESSION; HUMAN; NEOPLASM INVASIVENESS; ONCOGENE PROTEINS; PRECANCEROUS CONDITIONS; RNA, MESSENGER;

EID: 0028845863     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1295-1257     Document Type: Article

References (26)

1. Ohuchi, N. et al. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast. J. natn. Cancer Inst. 79, 109-117 (1987).
2. Lodato, R., Maguire, H., Greene, M., Weiner, D. & LiVolsi, V. Immunohistochemical evaluation of c-erb-B- oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast. Modem Path 3, 449-454 (1990).
3. Umekita, Y., Takasaki, T. & Yoshida, H. Expression of p53 protein in benign epithelial hyperplasia, atypical ductal hyperplasia, non-invasive and invasive mammary carcinoma: An immunohistochemical study. Virchows Archi. 424, 491-494 (1994)
4. Tsuda, H., Iwaya, K., Fukutomi, T. & Hirohashi, S. pS mutations and c-erb-B- amplification in intraductal and invasive breast carcinomas of high histological grade. Jpn. J. Cancer Res 84, 394-401 (1993).
5. Poller, D., Roberts, E., Bell, J., Elston, C., Blarney, R. & Ellis, I. p53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erb-B-protein. Hum. Path. 24, 463-468 (1993).
6. O'Malley, F. et al. D. p5, mutations are confined to the comdeo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data. Lab. Inves 71, 67-72 (1994).
7. Giri, D., Dundas, S., Nottingham, J. & Underwood, J. Oestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: An immunohis-tological study. Histopatholog 15, 575-584 (1989).
8. Bur, M., Zimarowski, M., Schnitt, S., Baker, S. & Lew, R. Estrogen receptor im-munohistochemistry in carcinoma in situ of the breast. Cance 69, 1174-1181 (1992).
9. O'Connell, P., Pekkel, V., Fuqua, S., Osborne, C. & Allred, C. Molecular genetic studies of early breast cancer evolution. Breast Cancer Res. Treat 32, 5-12 (1994).
10. Zhang, S.-Y., Camano, J., Cooper, F., Guo, X. & Klein-Szanto, A. Immunohistochemistry of cyclin D1 in human breast cancer. Am. J. cïin. Path 102, 695-698 (1994).
11. Gillett, C. et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54, 1812-1817 (1994).
12. Bartkova, J. et al. Cyclin D1 protein expression and function in human breast cancer. Int J. Cance 57, 353-361 (1994).
13. Wang, T. et al. Mammary hyperplasia and carcinoma in MMTV-cyclin Dł transgenic mice. Natur 369, 669-6, 1 (1994)
14. Sicinski, P. et al. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cel 82, 621-630 (1995).
15. Han, E. K.-H. et al. Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogen 10, 953-961 (1995).
16. Musgrove, E., Lee, C., Buckley, M. & Sutherland, R. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc. natn. Acad. Sci. U. S. A 91, 8022-8026 (1994).
17. Xiong, Y., Connolly, T., Futcher, B. & Beach, D. Human D-type cyclin. Cell 65, 691-699 (1991).
18. Pines, J. & Hunter, T. Human cyclin A is adenovirus ElA-associated protein p60 and behaves differently from cyclin B. Natur 346, 760-763 (1990).
19. Lukas, J., Pagano, M., Staskova, Z., Draetta, G. & Bartek, J. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 9, 707-718 (1994).
20. Page, D. & DuPont, W. Anatomic indicators (histologic and cytologic) of increased breast cancer risk. Breast Cancer Res. Treat 28, 157-166 (1993).
21. Page, D. & DuPont, W. Anatomic markers of human premalignancy and risk of breast cancer. Cancer 66, 1326-1335 (1990).
22. DuPont, W. & Page, D. Risk factors for breast cancer in women with proliferative breast disease. New Engl J. Med 312, 146-151 (1985).
23. Buckley, M. et al. Expression and amplification of cyclin genes in human breast cancer. Oncogen 8, 2127-2133 (1993).
24. Keyomarsi, K. & Pardee, A. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. natn. Acad. Sci. U. S. A. 90, 1112-1116 (1993).
25. Crissman, J. Visscher, W. & Kubus, J. Image cytophotometric DNA analysis of atypical hyperplasias and intraductal carcinomas of the breast. Arch. Path. lab. Med 114, 1249-1253 (1990).
26. Carpenter, R., Gibbs, N., Matthews, T. & Cooke, T. Importance of cellular DNA content in pre-malignant breast disease and pre-invasive carcinoma of the female breast. Br. J. Surg 74, 905-906 (1987).